SCHEMBL26852018

SCHEMBL26852018

NC(=O)c1nc(N)ccc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K3 P46734 3/20 0.56
NNMT P40261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39
GABRG3 Q99928 2/20 0.39
GABRQ Q9UN88 2/20 0.39
PDPK1 O15530 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668419 0.83 MAP2K3 (0.53) MAP2K3NNMTSMN1; SMN2PDPK1MEN1
SCHEMBL16505772 0.78 MAP2K3 (0.53) MAP2K3PDPK1MEN1KMT2AIKBKB
SCHEMBL15275826 0.78 GRM5 (0.54) MAP2K3PDPK1MEN1KMT2AIKBKB
SCHEMBL6833172 0.78 MAP2K3 (0.53) MAP2K3PDPK1MEN1KMT2AIKBKB
SCHEMBL16505248 0.78 MAP2K3 (0.53) MAP2K3PDPK1MEN1KMT2AIKBKB
SCHEMBL2159117 0.74 MAP2K3 (0.49) MAP2K3PDPK1KMT2AIKBKBALDH1A1
SCHEMBL11708941 0.74 MAPT (0.48) MAP2K3MEN1KMT2AALDH1A1HPGD
SCHEMBL14358203 0.74 NNMT (0.54) MAP2K3NNMTIKBKBMKNK1MKNK2
SCHEMBL31378785 0.72 MAP2K3 (0.51) MAP2K3
SCHEMBL27896613 0.72 MAP2K3 (0.51) MAP2K3MEN1KMT2AIKBKBMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217906-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 WO disclosed